Carebee Study

JRCT ID: jRCT1040240055

Registered date:03/07/2024

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: dementia
• Date of first enrollment: 12/06/2023
• Target sample size: 15
• Study type: Interventional

Intervention(s)

Step 1: A Hubbit employee visits the home of the person with dementia who has a caregiver to install, set up, and explain the Carebee terminal to the person and caregiver. One week after the installation of the device and four weeks after the installation of the device, the attending physician conducts a 10-15 minute remote consultation with the person and caregiver using this system.
Step 2: After the 4-week consultation in Step 1, the Carebee Supporter explains how to use the Carebee terminal to the patient only. 1 week and 4 weeks after the start of Step 2 (8 weeks in total), the attending physician conducts a remote consultation.

Outcome(s)

• Primary Outcome: Percentage of continued use of the system during the first 4 weeks of intervention.

Secondary Outcome

1) Percentage of continued use of the system at 8 weeks after the start of the intervention.
2) Time (minutes) assisted to start using the system after 4 weeks of intervention.

Key inclusion & exclusion criteria

• Age minimum: >= 65age old
• Age maximum: < 95age old
• Gender: Both

Include criteria

Persons with dementia (the person in question)
1) Age: 65 years old or older and less than 95 years old (at the time of obtaining consent). The age of the caregiver is not required.
2) Medical examination category: Outpatients. Patients must have been diagnosed with dementia while attending the outpatient clinic of the National Institute for Longevity Sciences. The type of dementia does not matter.
3) Must be accompanied by a reliable caregiver for the duration of the study and must give written consent (a reliable caregiver must be physically and mentally healthy, have contact with the subject for at least one hour per week, and be able to participate in all interventions until the end of the study).
4) MMSE of at least 11 points within 6 months prior to consent.
5)Patients who have given their written consent to participate in the study.
6)The line condition must be 1.7 Gbps to 1 Gbps maximum transmission speed at the time of reception.

Caregivers
1) Any age.
2)Must be physically and mentally healthy, have contact with the subject for at least one hour per week, and be able to participate in all interventions until the end of the study by the same person.
3) Written consent to participate in the study must be obtained from the caregiver.

Exclude criteria

1) Has severe hearing impairment, dysarthria, or aphasia.
2) Patients who are inconvenienced by the communication status of their smartphones in their home environment.
3) Other patients who are deemed inappropriate by the principal investigator and the subinvestigator.

Related Information

• Primary Sponsor: Yukihiko Washimi
• Source(s) of Monetary Support: National Center for Geriatrics and Gerontology